Researchers at King’s College London and the Wellcome Trust Sanger Institute in the United Kingdom have for the first time demonstrated a direct link between the Wbp2 gene and progressive hearing loss. The scientists report that the loss of Wbp2 expression leads to progressive high-frequency hearing loss in mouse as well as in two clinical cases of children with deafness with no other obvious features. The results are published in EMBO Molecular Medicine.
The scientists have shown that hearing impairment is linked to hormonal signalling rather than to hair cell degeneration. Wbp2 is known as a transcriptional co-activator for estrogen receptor Esr1 and progesterone receptor Pgr.
The loss of Wbp2 causes not only progressive high frequency hearing loss, but also results in reduced expression of Esr1, Esr2 and Pgr in the cochlea – a part of the inner ear. Understanding the estrogen-sensitive molecular networks specific to hearing offers an unprecedented putative new target for the control of the estrogen signalling pathway in the auditory system that could prevent or reverse progressive hearing loss.
“Our study demonstrates that hearing thresholds are normal in young Wbp2 mutant mice, but are raised at high frequencies by four weeks of age,” says EMBO Member Karen Steel of King’s College London, the senior author of the study. “More importantly, we also demonstrate that Wbp2 is crucial for hearing in humans. We found two children affected by severe to profound deafness, each carrying two variants of the WBP2 gene.”
Progressive hearing loss is a very common disease. However, very little is known about its molecular mechanisms. As a result, targets for medical therapies have been lacking. It has been known that estrogen signalling protects against noise-induced hearing loss. However, estrogen-based therapies have not been generally considered for hearing impairment due to their widespread effects. This study opens up the Wbp2 pathway as a new route to therapeutic approaches that more specifically target the inner ear.
Wbp2 was found to be involved in progressive hearing loss during a large-scale screen for hearing defects in newly-generated targeted mouse mutants. The finding of a new gene involved in human deafness following the initial discovery of its role in the mouse also emphasizes the value of mouse genetics research for better understanding human disease.
Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearing.
Annalisa Buniello, Neil J Ingham, Morag A Lewis, Andreea C Huma, Raquel Martinez-Vega, Isabel Varela-Nieto, Gema Vizcay-Barrena, Roland A Fleck, Oliver Houston, Tanaya Bardhan, Stuart L Johnson, Jacqueline K White, Huijun Yuan, Walter Marcotti, Karen P Steel
Read the paper: http://embomolmed.embopress.org/cgi/doi/10.15252/emmm.201505523
Further information on EMBO Molecular Medicine is available at www.embomolmed.embopress.org
Editor, EMBO Molecular Medicine
Tel: +49 6221 8891 411
EMBO is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.
EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe. For more information: www.embo.org
Yvonne Kaul | idw - Informationsdienst Wissenschaft
Could this protein protect people against coronary artery disease?
17.11.2017 | University of North Carolina Health Care
Microbial resident enables beetles to feed on a leafy diet
17.11.2017 | Max-Planck-Institut für chemische Ökologie
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
17.11.2017 | Physics and Astronomy
17.11.2017 | Health and Medicine
17.11.2017 | Studies and Analyses